...
首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Regulation of microglial process elongation, a featured characteristic of microglial plasticity
【24h】

Regulation of microglial process elongation, a featured characteristic of microglial plasticity

机译:对微胶质过程伸长的调节,微胶囊可塑性的特征

获取原文
获取原文并翻译 | 示例

摘要

Microglia, a type of glia within the brain characterized by a ramified morphology, are essential for removing neuronal debris and restricting the expansion of a lesion site. Upon moderate activation, they undergo a transformation in morphology inducing beneficial responses. However, upon strong stimulation, they mediate neuronal damage via production of pro-inflammatory cytokines. The inhibition of this cascade is considered an effective strategy for neuroinflammation-associated disorder therapy. During this pathological activation microglia also undergo a shortening of process length which contributes to the pathogenesis of such disorders. Thus, microglial plasticity should be considered to have two components: one is the production of inflammatory mediators, and the other is the dynamic changes in their processes. The former role has been well-documented in previous studies, while the latter one remains largely unknown. Recently, we and others have reported that the elongation of microglial process is associated with the transformation of microglia from a pro-inflammatory to an anti-inflammatory state, suggesting that the shortening of process length would make the microglia lose their ability to restrict pathological injury, while the elongation of microglial process would help attenuate neuroinflammation. Compared with the traditional anti-neuroinflammatory strategy, stimulating elongation of microglial process not only reduces the production of pro-inflammatory cytokines, but restores the ability of microglia to scan their surrounding environments, thus rendering their homeostasis regulation more effective. In this review, we provide a discussion of the factors that regulate microglial process elongation in vitro and in vivo, aiming to further drive the understanding of microglial process plasticity.
机译:微胶质细胞,一种脑内的胶质细胞,其特征在于被偶然的形态,对除去神经元碎片并限制病变部位的扩张是必不可少的。激活中度激活后,它们经历了诱导有益响应的形态转化。然而,在强烈刺激后,它们通过生产促炎细胞因子介导神经元损伤。这种级联的抑制被认为是神经炎症相关疾病治疗的有效策略。在该病理激活期间,微胶质细胞也经过缩短过程长度,这有助于这种疾病的发病机制。因此,应考虑微胶质可塑性具有两个组分:一个是炎症介质的产生,另一个是其过程中的动态变化。以前的角色在以前的研究中已经充分记录,而后者仍然很大程度上是未知数。最近,我们和其他人据报道,微胶囊过程的伸长率与微胶质细胞的转化与促炎症到抗炎状态的转化相关,这表明过程长度的缩短将使小胶质细胞失去限制病理损伤的能力,虽然小胶囊过程的伸长率有助于衰减神经炎症炎症。与传统的抗神经炎策略相比,刺激微胶质过程的伸长率不仅减少了促炎细胞因子的生产,而且恢复了微胶质细胞的能力扫描周围环境,从而使其稳态调节更有效。在本文中,我们提供了对体外和体内微胶质过程伸长的因素的讨论,旨在进一步推动对微胶囊过程可塑性的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号